Cargando…

Xuanfei Pingchuan Capsules Ameliorate Autophagy in Human Bronchial Epithelial Cells by Inhibiting p38 Phosphorylation

Background: This study aimed to investigate the protective effect of Xuanfei Pingchuan Capsules (XFPC) on autophagy and p38 phosphorylation in human bronchial epithelial (HBE) cells induced by cigarette smoke extract (CSE). Methods: HBE cells were divided into five groups: blank, CSE, low XFPC dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Xiaoming, Meng, Lihong, Cai, Hongyu, Sun, Yaoqin, Zhang, Ye, Li, Hao, Kang, Yu, Zhou, Bobo, Shang, Fang, Guan, Wei, Zhang, Li, Chen, Xu, Zhang, Luodan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678282/
https://www.ncbi.nlm.nih.gov/pubmed/34925010
http://dx.doi.org/10.3389/fphar.2021.748234
_version_ 1784616298233200640
author Xue, Xiaoming
Meng, Lihong
Cai, Hongyu
Sun, Yaoqin
Zhang, Ye
Li, Hao
Kang, Yu
Zhou, Bobo
Shang, Fang
Guan, Wei
Zhang, Li
Chen, Xu
Zhang, Luodan
author_facet Xue, Xiaoming
Meng, Lihong
Cai, Hongyu
Sun, Yaoqin
Zhang, Ye
Li, Hao
Kang, Yu
Zhou, Bobo
Shang, Fang
Guan, Wei
Zhang, Li
Chen, Xu
Zhang, Luodan
author_sort Xue, Xiaoming
collection PubMed
description Background: This study aimed to investigate the protective effect of Xuanfei Pingchuan Capsules (XFPC) on autophagy and p38 phosphorylation in human bronchial epithelial (HBE) cells induced by cigarette smoke extract (CSE). Methods: HBE cells were divided into five groups: blank, CSE, low XFPC dose (XFPC-L), medium XFPC dose (XFPC-M), and high XFPC dose (XFPC-H). HBE cells were induced by CSE to establish a cell model for chronic obstructive pulmonary disease, and different doses of XFPC medicated serum were used to treat the cells. The Cell Counting Kit-8 was used to detect cell viability. Flow cytometry was used to detect cell apoptosis. Fluorescence microscopy and the expression level of microtubule-associated protein light chain 3 (LC3)-II in immunohistochemical method were used to observe autophagy in cells. Western blot was used to detect the protein expression level of p38, phospho-p38 (p-p38), LC3-I, LC3-II and Beclin 1. Real-time polymerase chain reaction was used to detect the expression of LC3-I, LC3-II and Beclin 1 on mRNA level. Results: Compared with the blank group, the cell viability of the CSE group was significantly decreased, and apoptosis and the level of autophagy in cells were significantly increased. The mRNA and protein expression of LC3-I, LC3-II, Beclin 1 and the protein level of p-p38 were significantly increased in the CSE-HBE cells. Compared to the CSE group, the different doses of XFPC medicated serum increased cell viability, decreased cell apoptosis, and inhibited mRNA and protein expression of LC3-I, LC3-II, Beclin 1 and protein level of p-p38. These results were especially observed in the group XFPC-H. After adding a p38 agonist, the therapeutic effect of XFPC on cell viability and autophagy was suppressed. Conclusion: XFPC significantly increased cell viability in a CSE-induced HBE cell model for chronic obstructive pulmonary disease through inhibiting the level of autophagy mediated by phosphorylation of p38.
format Online
Article
Text
id pubmed-8678282
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86782822021-12-18 Xuanfei Pingchuan Capsules Ameliorate Autophagy in Human Bronchial Epithelial Cells by Inhibiting p38 Phosphorylation Xue, Xiaoming Meng, Lihong Cai, Hongyu Sun, Yaoqin Zhang, Ye Li, Hao Kang, Yu Zhou, Bobo Shang, Fang Guan, Wei Zhang, Li Chen, Xu Zhang, Luodan Front Pharmacol Pharmacology Background: This study aimed to investigate the protective effect of Xuanfei Pingchuan Capsules (XFPC) on autophagy and p38 phosphorylation in human bronchial epithelial (HBE) cells induced by cigarette smoke extract (CSE). Methods: HBE cells were divided into five groups: blank, CSE, low XFPC dose (XFPC-L), medium XFPC dose (XFPC-M), and high XFPC dose (XFPC-H). HBE cells were induced by CSE to establish a cell model for chronic obstructive pulmonary disease, and different doses of XFPC medicated serum were used to treat the cells. The Cell Counting Kit-8 was used to detect cell viability. Flow cytometry was used to detect cell apoptosis. Fluorescence microscopy and the expression level of microtubule-associated protein light chain 3 (LC3)-II in immunohistochemical method were used to observe autophagy in cells. Western blot was used to detect the protein expression level of p38, phospho-p38 (p-p38), LC3-I, LC3-II and Beclin 1. Real-time polymerase chain reaction was used to detect the expression of LC3-I, LC3-II and Beclin 1 on mRNA level. Results: Compared with the blank group, the cell viability of the CSE group was significantly decreased, and apoptosis and the level of autophagy in cells were significantly increased. The mRNA and protein expression of LC3-I, LC3-II, Beclin 1 and the protein level of p-p38 were significantly increased in the CSE-HBE cells. Compared to the CSE group, the different doses of XFPC medicated serum increased cell viability, decreased cell apoptosis, and inhibited mRNA and protein expression of LC3-I, LC3-II, Beclin 1 and protein level of p-p38. These results were especially observed in the group XFPC-H. After adding a p38 agonist, the therapeutic effect of XFPC on cell viability and autophagy was suppressed. Conclusion: XFPC significantly increased cell viability in a CSE-induced HBE cell model for chronic obstructive pulmonary disease through inhibiting the level of autophagy mediated by phosphorylation of p38. Frontiers Media S.A. 2021-12-02 /pmc/articles/PMC8678282/ /pubmed/34925010 http://dx.doi.org/10.3389/fphar.2021.748234 Text en Copyright © 2021 Xue, Meng, Cai, Sun, Zhang, Li, Kang, Zhou, Shang, Guan, Zhang, Chen and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Xue, Xiaoming
Meng, Lihong
Cai, Hongyu
Sun, Yaoqin
Zhang, Ye
Li, Hao
Kang, Yu
Zhou, Bobo
Shang, Fang
Guan, Wei
Zhang, Li
Chen, Xu
Zhang, Luodan
Xuanfei Pingchuan Capsules Ameliorate Autophagy in Human Bronchial Epithelial Cells by Inhibiting p38 Phosphorylation
title Xuanfei Pingchuan Capsules Ameliorate Autophagy in Human Bronchial Epithelial Cells by Inhibiting p38 Phosphorylation
title_full Xuanfei Pingchuan Capsules Ameliorate Autophagy in Human Bronchial Epithelial Cells by Inhibiting p38 Phosphorylation
title_fullStr Xuanfei Pingchuan Capsules Ameliorate Autophagy in Human Bronchial Epithelial Cells by Inhibiting p38 Phosphorylation
title_full_unstemmed Xuanfei Pingchuan Capsules Ameliorate Autophagy in Human Bronchial Epithelial Cells by Inhibiting p38 Phosphorylation
title_short Xuanfei Pingchuan Capsules Ameliorate Autophagy in Human Bronchial Epithelial Cells by Inhibiting p38 Phosphorylation
title_sort xuanfei pingchuan capsules ameliorate autophagy in human bronchial epithelial cells by inhibiting p38 phosphorylation
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678282/
https://www.ncbi.nlm.nih.gov/pubmed/34925010
http://dx.doi.org/10.3389/fphar.2021.748234
work_keys_str_mv AT xuexiaoming xuanfeipingchuancapsulesameliorateautophagyinhumanbronchialepithelialcellsbyinhibitingp38phosphorylation
AT menglihong xuanfeipingchuancapsulesameliorateautophagyinhumanbronchialepithelialcellsbyinhibitingp38phosphorylation
AT caihongyu xuanfeipingchuancapsulesameliorateautophagyinhumanbronchialepithelialcellsbyinhibitingp38phosphorylation
AT sunyaoqin xuanfeipingchuancapsulesameliorateautophagyinhumanbronchialepithelialcellsbyinhibitingp38phosphorylation
AT zhangye xuanfeipingchuancapsulesameliorateautophagyinhumanbronchialepithelialcellsbyinhibitingp38phosphorylation
AT lihao xuanfeipingchuancapsulesameliorateautophagyinhumanbronchialepithelialcellsbyinhibitingp38phosphorylation
AT kangyu xuanfeipingchuancapsulesameliorateautophagyinhumanbronchialepithelialcellsbyinhibitingp38phosphorylation
AT zhoubobo xuanfeipingchuancapsulesameliorateautophagyinhumanbronchialepithelialcellsbyinhibitingp38phosphorylation
AT shangfang xuanfeipingchuancapsulesameliorateautophagyinhumanbronchialepithelialcellsbyinhibitingp38phosphorylation
AT guanwei xuanfeipingchuancapsulesameliorateautophagyinhumanbronchialepithelialcellsbyinhibitingp38phosphorylation
AT zhangli xuanfeipingchuancapsulesameliorateautophagyinhumanbronchialepithelialcellsbyinhibitingp38phosphorylation
AT chenxu xuanfeipingchuancapsulesameliorateautophagyinhumanbronchialepithelialcellsbyinhibitingp38phosphorylation
AT zhangluodan xuanfeipingchuancapsulesameliorateautophagyinhumanbronchialepithelialcellsbyinhibitingp38phosphorylation